Atrium Medical Corporation, a Subsidiary of Getinge, Divests its Biosurgery Business to HJ Capital 1, the Parent Company of SeCQure Surgical Corporation

GOTHENBURG, Sweden, Oct. 18, 2018

The biosurgery business was added to Getinge's therapeutic portfolio via the acquisition of Atrium Medical in 2011. The business is dedicated to the development of biological, mechanical and therapeutic solutions for soft tissue reinforcement following trauma, surgery and other interventional procedures. The biosurgery business has been a relatively small segment within Getinge's overall portfolio and the only therapeutic asset in the general surgery field. The divestment is a strategic decision in order to focus on core therapeutic solutions.

The divestment of the biosurgery business is a carve-out of assets from the Atrium Medical business. The divestment includes all assets and liabilities relating to the biosurgery business, but excludes the mesh product liability claims raised against Atrium Medical in relation to products sold prior to closing and also the associated insurance claims of Atrium Medical.

SeCQure Surgical is a company that provides versatile system configurations in general surgical for both minimally invasive and traditional open procedures including energy systems, surgical staplers and surgical mesh.

Media contact:
Lars Mattsson, Head of Investor Relations
Phone: +46 (0)10-335-0043
E-mail: lars.mattsson@getinge.com

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/getinge/r/atrium-medical-corporation--a-subsidiary-of-getinge--divests-its-biosurgery-business-to-hj-capital-1,c2647860